drugset / Trial / NCT02389790
Extension Study of MT-1303 in Subjects With Crohn's Disease
NaSingle-groupOpen-labelTreatment
Summary
The primary objectives of the study are: -To evaluate the long-term safety and tolerability of MT-1303 in subjects with moderate to severe active Crohn's Disease(CD)
Timeline
- Start
- 2015-08
- Primary completion
- 2017-08
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amiselimod | Small molecule | — | — |